Investor Presentaiton
Important notice
This presentation has been prepared by AFT Pharmaceuticals Limited ("AFT"), to provide a general overview of the
performance of AFT for the half year ended 30 September 2021. It is not prepared for any other purpose and must not be
provided to any person other than the intended recipient.
This presentation should be read in conjunction with AFT's interim financial statements, market releases and other periodic
and continuous disclosure announcements, which are available at www.nzx.com and www.asx.com.au.
All amounts are disclosed in New Zealand dollars (NZ$) unless otherwise indicated.
All references to financial years appearing in this presentation are for the period ending 31 March, unless otherwise
indicated. This presentation is not a recommendation, offer or invitation to acquire AFT's securities or other form of
financial advice or disclosure document.
While reasonable care has been taken in compiling this presentation, none of AFT nor its subsidiaries, directors, employees,
agents or advisers (to the maximum extent permitted by law) gives any warranty or representation (express or implied) of
the accuracy, completeness or reliability of the information contained in it nor takes any responsibility for it.
The information in this presentation has not been and will not be independently verified or audited. This presentation may
contain certain forward-looking statements and comments about future events, including with respect to the financial
condition, results, operations and business of AFT.
These statements are based on management's current expectations, which may involve significant elements of subjective
judgement and assumptions as to future events which may or may not be correct, and the actual events or results may
differ materially and adversely from these statements. Past performance information given in this presentation is given for
illustrative purposes only and should not be relied upon (and is not) an indication of future performance.
AFTpharmaceuticals
Page 2View entire presentation